$2.14
al cierre: Oct 31, 10:24 AM EDT
Comments
Loading...
Eagle Pharmaceuticals Informe de interés a corto plazo
EGRXOTCEM
Informe de interés en corto
El interés corto en Eagle Pharmaceuticals Inc (OTC:EGRX) ha disminuido durante el último período de informe, aumentando en descenso desde 42.09K hasta 42.04K. Esto representa el 0.5% de las acciones disponibles públicamente de la empresa.
El interés en corto en Eagle Pharmaceuticals Corp (OOTC:EGRX) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 10.48K acciones negociadas por día, tomaría 4.01 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Interés en corto
42.04K
Interés en corto %
0.50%
Días para cubrir
4.01
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
EGRX | EAGLE PHARMACEUTICALS INC Comm | 10/15/2025 | 10/24/2025 | 0.50% | 8,359,524 | 42,040 | 10,478 | 4.01 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 09/30/2025 | 10/09/2025 | 0.50% | 8,359,524 | 42,091 | 4,542 | 9.27 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 09/15/2025 | 09/24/2025 | 0.51% | 8,359,524 | 42,221 | 3,140 | 13.45 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 08/29/2025 | 09/10/2025 | 0.50% | 8,359,524 | 42,212 | 412 | 102.46 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 08/15/2025 | 08/26/2025 | 0.50% | 8,359,524 | 42,122 | 1,121 | 37.58 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 07/31/2025 | 08/11/2025 | 0.50% | 8,359,524 | 42,197 | 744 | 56.72 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 07/15/2025 | 07/24/2025 | 0.51% | 8,359,524 | 42,806 | 6,638 | 6.45 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 06/30/2025 | 07/10/2025 | 0.50% | 8,359,524 | 42,183 | 4,726 | 8.93 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 06/13/2025 | 06/25/2025 | 0.51% | 8,359,524 | 42,512 | 16,442 | 2.59 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 05/30/2025 | 06/10/2025 | 0.51% | 8,359,524 | 42,541 | 6,580 | 6.47 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 05/15/2025 | 05/27/2025 | 0.65% | 8,359,524 | 54,378 | 2,182 | 24.92 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 04/30/2025 | 05/09/2025 | 0.76% | 8,359,524 | 63,803 | 27,217 | 2.34 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 04/15/2025 | 04/25/2025 | 1.35% | 8,359,524 | 112,764 | 30,099 | 3.75 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 03/31/2025 | 04/09/2025 | 1.35% | 8,359,524 | 112,851 | 3,707 | 30.44 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 03/14/2025 | 03/25/2025 | 1.35% | 8,359,524 | 112,473 | 8,363 | 13.45 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 02/28/2025 | 03/11/2025 | 1.35% | 8,359,524 | 112,473 | 21,017 | 5.35 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 02/14/2025 | 02/26/2025 | 1.48% | 8,359,524 | 123,405 | 15,137 | 8.15 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 01/31/2025 | 02/11/2025 | 4.04% | 8,359,524 | 337,651 | 24,487 | 13.79 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 01/15/2025 | 01/27/2025 | 4.32% | 8,359,524 | 360,970 | 10,362 | 34.84 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 12/31/2024 | 01/10/2025 | 4.31% | 8,359,524 | 360,147 | 57,663 | 6.25 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 12/13/2024 | 12/24/2024 | 4.15% | 8,359,524 | 346,791 | 32,482 | 10.68 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 11/29/2024 | 12/10/2024 | 4.15% | 8,359,524 | 346,662 | 48,320 | 7.17 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 11/15/2024 | 11/26/2024 | 4.23% | 8,359,524 | 353,263 | 92,024 | 3.84 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 10/31/2024 | 11/11/2024 | 3.42% | 8,359,524 | 285,794 | 75,762 | 3.77 | |
EGRX | EAGLE PHARMACEUTICALS INC Comm | 10/15/2024 | 10/24/2024 | 3.63% | 8,359,524 | 303,619 | 1,056,855 | 1 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 09/30/2024 | 10/09/2024 | 4.44% | 8,359,524 | 371,552 | 79,390 | 4.68 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 09/13/2024 | 09/24/2024 | 4.19% | 8,359,524 | 350,531 | 106,586 | 3.29 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 08/30/2024 | 09/11/2024 | 5.07% | 8,359,524 | 423,835 | 79,273 | 5.35 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 08/15/2024 | 08/26/2024 | 5.79% | 8,359,524 | 484,164 | 91,080 | 5.32 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 07/31/2024 | 08/09/2024 | 5.08% | 8,359,524 | 424,439 | 125,632 | 3.38 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 07/15/2024 | 07/24/2024 | 9.22% | 8,359,524 | 770,581 | 143,596 | 5.37 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 06/28/2024 | 07/10/2024 | 11.08% | 8,359,524 | 925,908 | 361,118 | 2.56 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 06/14/2024 | 06/26/2024 | 11.89% | 8,359,524 | 994,352 | 114,723 | 8.67 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 05/31/2024 | 06/11/2024 | 12.94% | 8,359,524 | 1,081,335 | 215,692 | 5.01 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 05/15/2024 | 05/24/2024 | 13.62% | 8,359,524 | 1,138,859 | 107,130 | 10.63 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 04/30/2024 | 05/09/2024 | 14.38% | 8,359,524 | 1,202,370 | 131,233 | 9.16 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 04/15/2024 | 04/24/2024 | 14.08% | 8,359,524 | 1,177,408 | 192,398 | 6.12 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 03/28/2024 | 04/09/2024 | 14.47% | 8,359,524 | 1,209,368 | 115,302 | 10.49 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 03/15/2024 | 03/26/2024 | 13.91% | 8,359,524 | 1,162,791 | 130,867 | 8.89 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 02/29/2024 | 03/11/2024 | 13.31% | 8,359,524 | 1,112,573 | 146,627 | 7.59 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 02/15/2024 | 02/27/2024 | 12.72% | 8,359,524 | 1,063,267 | 315,838 | 3.37 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 01/31/2024 | 02/09/2024 | 9.49% | 8,388,268 | 796,104 | 353,833 | 2.25 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 01/12/2024 | 01/24/2024 | 8.62% | 8,388,268 | 723,081 | 271,498 | 2.66 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 12/29/2023 | 01/10/2024 | 8.31% | 8,388,268 | 697,355 | 274,203 | 2.54 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 12/15/2023 | 12/27/2023 | 8.00% | 8,388,268 | 671,287 | 270,429 | 2.48 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 11/30/2023 | 12/11/2023 | 7.04% | 8,388,268 | 590,396 | 290,069 | 2.04 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 11/15/2023 | 11/27/2023 | 7.09% | 8,388,268 | 594,600 | 140,920 | 4.22 | |
EGRX | Eagle Pharmaceuticals, Inc. Co | 10/31/2023 | 11/09/2023 | 7.36% | 8,388,268 | 617,629 | 76,795 | 8.04 |
En busca de los valores más cortos?